Wednesday, August 6, 2025

Well Health Technologies Corp

Sound bite for Twitter is: Heath Care Sector stock. Results of stock price testing is that the stock price is probably cheap, but it could just be reasonable. Debt Ratios are mostly fine, but they need to improve their Liquidity Ratio. This company does not pay a dividend so there is no dividend yield information and no Dividend Payout Ratios (DPR). See my spreadsheet on Well Health Technologies Corp.

Is it a good company at a reasonable price? I bought shares in the company last week. I bought them with my fooling around money in the TFSA. It is a small but growing company. It is a high risk. The stock price might be on the cheap side.

I own this stock of Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF). I was interested in this stock when I heard it was to acquire Toronto based MyHealth Centers. See report on Newswire.

When I was updating my spreadsheet, I noticed that it seems that British Columbia and Quebec seem to be able to grow small companies. Ontario does not. This company is out of British Columbia. I noticed that the Chairman owns some 6% of the outstanding shares. All the officers and directors I follow have bought shares over the past 12 months.

If you had invested in this company in December 2017, for $1,000.12 you would have bought 2,273 shares at $0.44 per share. In December 2024, after 7 years you would have received $0.00 in dividends. The stock would be worth $15,592.78. Your total return would have been $15,592.78. This would be a total return of 14.03% per year with 12.56% from capital gain and 1.47% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$0.44 $1,000.12 2,273 7 $0.00 $15,592.78 $15,592.78

This company does not pay a dividend so there is no dividend yield information and no Dividend Payout Ratios (DPR).

Debt Ratios are mostly fine, but they need to improve their Liquidity Ratio. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.20 and currently at 0.32. The Liquidity Ratio for 2024 is far too low at 0.91 and 0.92 currently. If you added in Cash Flow after dividends, the ratios are still far too low at 0.93 and currently at 0.94. The Debt Ratio for 2024 is good at 2.06 and 2.01 currently. The Leverage and Debt/Equity Ratios for 2024 are fine at 2.08 and 1.01 and currently at 2.17 and 1.08.

Type Year End Ratio Curr
Lg Term R 0.20 0.32
Intang/GW 0.67 0.98
Liquidity 0.91 0.92
Liq. + CF 0.93 0.95
Debt Ratio 2.06 2.01
Leverage 2.08 2.17
D/E Ratio 1.01 1.08


The Total Return per year is shown below for years of 5 to 7 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 0.00% 34.47% 34.47% 0.00%
2017 7 0.00% 48.05% 48.05% 0.00%

The 5-year low, median, and high median Price/Earnings per Share Ratios are essentially 0 or non-calculable. The corresponding 6 year ratios are negative and so useless. The current P/E Ratio is 118.75 based on a stock price of $4.75 and EPS estimate for $0.04. This is a really high P/E Ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 12.86, 19.50 and 26.14. The corresponding 7 year ratios are 10.96, 16.33 and 21.71. The current P/AEPS Ratio is 12.84 based on a stock price of $4.75 and AEPS estimate for 2025 of $0.37. This is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $5.24. The 4-year low, median, and high median Price/Graham Price Ratios are 1.34, 1.26 and 1.35. The current P/GP Ratio is 0.91 based on a stock price of $4.75. This stock price testing suggests that the stock price is relatively cheap. There have only been positive earnings for the last 4 years.

I get a 7-year median Price/Book Value per Share Ratio of 1.43. The current P/B Ratio is 1.44 based on a Book Value $834M, Book Value per Share of $1.67 and a stock price of $4.75. The current ratio is 0.4% above the 7 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and at the median.

I get a 7-year median Price/Cash Flow per Share Ratio of 5.92. The current ratio is 41.10 based on cash flow for the last 12 months of $29.2M, Cash Flow per Share of $0.12 and a stock price of $4.75. The current ratio is 595% above the 7 year median ratio. This stock price testing suggests that the stock price is relatively expensive. The Cash Flow is quite volatile.

I cannot do any dividend yield testing because this stock has no dividend.

The 6-year median Price/Sales (Revenue) Ratio is 2.46. The current P/S Ratio is 0.85 based on Revenue estimate for 2025 of $1,413M, Revenue per Share of $5.59 and a stock price of $4.75. The current P/S Ratio is 65% below the 6 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably cheap, but it could just be reasonable. The P/S Ratio test is saying this and this is good test. The P/AEPS Ratio test is saying that the stock price is reasonable and below the median. This is a good test.

When I look at analysts’ recommendations, I find Strong Buy (7), Buy (6), and Hold (1). The consensus is a Strong Buy. The 12 month stock price consensus is $7.65 with a high of $9.00 and low of $5.25. The consensus stock price of $7.65 implies a total return of 61.05% all from capital gains.

There are quite a few entries on Stock Chase in 2025 for this company. Some seem to think it is a buy, but others are cautious. One analyst thought that debt and cash flow need to improve for the stock to go higher. Amy Legate-Wolfe on Motley Fool thinks this stock is due for a comeback. She thinks that it is currently selling at an attractive price. Rajiv Nanjapla on Motley Fool thinks that this company has good growth prospects. The company put out a Press Release about their fourth quarter of 2024. The company put out a Press Release about their first quarter of 2025.

Simply Wall Street via Yahoo Finance likes that there is a 22.6% insider ownership for this company. Simply Wall Street via Yahoo Finance takes a look at this company and thinks that the consensus price target of $7.63 and thinks that this price target might be too pessimistic. Simply Wall Street shows no warnings for this stock.

An article dated October 17, 2024 talks about Hong Kong Billionaire Solian Chau buying a 14% stake in this company. There is an article on CANTECH about Stifel analyst Justin Keywood recommending this stock in June 2025.

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services. Its web site is here Well Health Technologies Corp.

The last stock I wrote about was about was Stingray Digital Group Inc (TSX-RAY.A, OTC-STGYF) ... learn more. The next stock I will write about will be BlackBerry Ltd (TSX-BB, NYSE-BB) ... learn more on Friday, August 8, 2025 around 5 pm. Tomorrow on my other blog I will write about Something to Buy August 2025.... .... learn more on Thursday, August 7, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, August 4, 2025

Stingray Digital Group Inc

Sound bite for Twitter is: Dividend Paying Consumer. Results of stock price testing is that the stock price could still be reasonable, but be cautious. Debt Ratios are fine, but the company has a lot of debt. The Dividend Payout Ratios (DPR) are fine. The current dividend yield is moderate with dividend growth stopped. See my spreadsheet on Stingray Digital Group Inc.

Is it a good company at a reasonable price? I have done fine with this stock. I have made several purchases over the years. I am planning on holding on to what I have. I have no plans on buying more, but then I currently have no spare money in my TFSA account. The stock is at a high, so generally that is not a good time to buy. The price could be reasonable, but it also could be on the expensive side.

I own this stock of Stingray Digital Group Inc (TSX-RAY.A, OTC-STGYF). I found this an interesting small cap, so I bought for my TFSA account.

When I was updating my spreadsheet, I noticed that I have this year made a good return on my investment. My Total Return is 11.38% per year with 7.69% from capital gains and 3.69% from dividends. I have had this stock for almost 7 years. It would be nice if they increased the dividends again. They have been flat since 2021.

If you had invested in this company in December 2014, for $1,000.50 you would have bought 138 shares at $7.25 per share. In December 2024, after 10 years you would have received $340.86 in dividends. The stock would be worth $1,041.90. Your total return would have been $1,382.76. This would be a total return of 3.67% per year with 0.41% from capital gain and 3.26% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$7.25 $1,000.50 138 10 $340.86 $1,041.90 $1,382.76

See Total Returns below when I use the last 10 years to the end of December 2024 and to the end of the financial year of March 2025. The stock price is up almost 38% this year so far.

The current dividend yield is moderate with dividend growth stopped. The dividend yield is moderate (2% to 4% ranges) at 2.88%. The 5 year median dividend yield is good (5% and 6% ranges) at 5%. The 9 year and historical dividend yields are also moderate at 3.91%. Dividend increases stopped in 2022. Analysts do not see any change in the near future.

The Dividend Payout Ratios (DPR) are fine. The DPR for 2024 for Earnings per Share (EPS) is too high at 57% with 5 year coverage at 82%. However, the DPR for AEPS is more important. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 29% with 5 year coverage at 37%. The DPR for 2024 for Adjusted Free Cash Flow (AFCF) is high at 57% with 5 year coverage at 81%. These ratios would be better in the 40% range or lower. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 16% with 5 year coverage at 19%. The DPR for 2024 for Free Cash Flow (FCF) is good at 28% with 5 year coverage at 30%. Here again, there is no agreement on what the FCF is, but they are not that far off.

Item Cur 5 Years
EPS 56.60% 81.52%
AEPS 28.57% 34.78%
AFCF 56.60% 81.52%
CFPS 16.14% 18.76%
FCF 28.12% 30.25%

Debt Ratios are fine, but the company has a lot of debt. The Long Term Debt/Market Cap Ratio for 2024 is fine at 0.56 and currently good at 0.48. The Liquidity Ratio for 2024 is too low at 1.00 and 1.00 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.64 and currently at 1.80. The Debt Ratio for 2024 is good at 1.49 and 1.49 currently. The Leverage and Debt/Equity Ratios for 2024 are too high at 3.06 and 2.06 and currently at 3.06 and 2.06. These would be better at if they were below 3.00 and 2.00.

Type Yr End Ratio Curr
Lg Term R 0.56 0.48
Intang/GW 1.04 0.90
Int less BL 0.60 0.51
Liquidity 1.00 1.00
Liq. + CF 1.64 1.80
Debt Ratio 1.49 1.49
Leverage 3.06 3.06
D/E Ratio 2.06 2.06

The Total Return per year is shown below for years of 5 to 10 to the end of December 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 1.39% 5.24% 1.12% 4.11%
2014 10 10.22% 3.67% 0.41% 3.26%

There is quite a difference when using the March financial year as the year ends. The Total Return per year is shown below for years of 5 to 10 to the end of March 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 1.39% 23.25% 17.59% 5.67%
2014 10 10.22% 5.15% 2.15% 3.00%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 9.58, 13.22 and 16.86. The corresponding 10 year ratios are 13.32, 15.38 and 17.45. The corresponding historical ratios are 13.32, 15.38 and 17.45. The current P/E Ratio is 11.78 based on a stock price of $10.72 and EPS estimate for 2026 of $0.91. The current ratio is below the low ratio for the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earnings per Share (AEPS) Data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 5.22, 7.20 and 9.18. The corresponding 10 year ratios are 7.33, 8.46 and 10.54. The current P/AEPS ratio is 8.38 based on a stock price of $10.72 and AEPS estimate for 2026 of 1.28. The current ratio is between the low and median ratio of the 10 year ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $10.62. The 10-year low, median, and high median Price/Graham Price Ratios are 0.75, 0.86 and 1.00. The current ratio is 1.01 based on a stock price of $10.72. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 1.99. The current P/B Ratio is 2.74 based on a stock price of $10.72, Book Value of $267M and Book Value per Share of $3.92. The current ratio is 37% above the 10 year ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have an estimate for the Book Value per Share for 2026 of $4.67. This implies a ratio of 2.30 with a stock price of $10.72 and Book Value of $318M. This ratio is 15% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 5.76. The current P/CF Ratio is 5.73 based on a stock price of $10.72, Cash Flow per Share estimate for 2026 of $1.87 and Cash Flow of $127M. The current ratio is 0.5% below 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical and 10 year median dividend yield of 3.91%. The current dividend yield is 2.88% based on a dividend of $0.30 and a stock price of $10.72. The current dividend yield is 26% below the historical and 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This test works best with increasing dividends and the dividend increases were stopped in 2022.

The 10-year median Price/Sales (Revenue) Ratio is 1.80. The current P/S Ratio is 1.76 based Revenue estimate for 2026 of $415.3M, Revenue per Share of $6.10 and a stock price of $10.72. The current ratio is 2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price could still be reasonable, but be cautious. The P/S Ratio testing is saying that the stock price is reasonable. However, the dividend yield testing is saying that the stock price is expensive. There is a problem with this test as it works better with increasing dividends and here the dividends are flat. However, a company that stops dividend increases is showing problems. For the rest of the testing, it goes from cheap to expensive.

When I look at analysts’ recommendations, I find Strong Buy (3) and Buy (3). The consensus would be a Strong Buy. The 12 months target price is $13.12 with a high of $13.50 and low of $13.00. The 12 month target price of $13.12 implies a total return of 28.91% with 26.03% from capital gains and 2.88% from dividends.

The last comment on Stock Chase for this stock is in 2023. Analysts says that the company is profitable but concentrated in Canada. He is watching it. Christopher Liew on Motley Fool says that Stingray Group is viable because of numerous growth catalysts and opportunities. Christopher Liew on Motley Fool wrote about this stock also in January 2025. He seems to be the only one on Motley Fool covering this stock. The company put out a Press Release about their fourth quarter results for 2025.

Simply Wall Street via Yahoo Finance talks about this stock because it is a growth stock with insider ownership up to 22%.

Stingray Group Inc is a provider of multi-platform music services. It broadcasts music and video content on several platforms, including radio stations, premium television channels, digital TV, satellite TV, IPTV, the Internet, mobile devices, and game consoles. Geographically, the company derives its key revenue from Canada and the rest from the United States and other countries. Its web site is here Stingray Digital Group Inc.

The last stock I wrote about was about was Loblaw Companies Ltd (TSX-L, OTC-LBLCF) ... learn more. The next stock I will write about will be Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF) ... learn more on Wednesday, August 6, 2025 around 5 pm. Tomorrow on my other blog I will write about Dividend Stocks August 2025.... .... learn more on Tuesday, August 5, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, August 1, 2025

Loblaw Companies Ltd

Sound bite for Twitter is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably relatively expensive. Some Debt Ratios are fine, but the company has too much debt. The Dividend Payout Ratios (DPR) are good. The current dividend yield is Low with dividend growth moderate. See my spreadsheet on Loblaw Companies Ltd.

Is it a good company at a reasonable price? This company seems to be doing very well at present. It does seem to be at all time high. I know that analysts have a buy rating on this stock, but generally speaking most analysts’ recommendations consensus is a Buy. The best way to buy any company for the long term, is to buy shares over a period of years and in different months. All my testing is pointing to the stock price as being on the expensive side.

I do not own this stock of Loblaw Companies Ltd (TSX-L, OTC-LBLCF), but I used to. I owned it from 1996 to 2007. It was originally a great stock. I sold it in 2007 because it was having problems with its tech upgrade to its supply system and it did not seem that it would be fixed anytime soon.

When I was updating my spreadsheet, I noticed that this stock started to do well again from 2014. However, I had replaced Loblaws with Metro and Metro has done well for me and it is a pure grocery stock. Loblaws is more than just groceries as it has real estate and Shoppers Drug Mart. This company had a very good year in 2024.

I noticed that if I had kept my stock to this date, I would have probably earned 11.38% per year with 9.30% from capital gains and 2.08% from dividends. That would be over a period of just 28 years. I had made two purchases, one in 1996 and one in 1998. So, in the end, I would not have done badly.

The company had problems and hit a low in 2008. That was 16 years ago and it has recovered. The stock hit a high in 2004 and it took the stock 11 years, until 2015 to get back to this high. People who bought this stock in 2004, just over 20 years ago have earned over past 20 years to 2024, 5.89% total return per year with 4.95% from capital gains and 0.94% from dividends. See chart below.

If you had invested in this company in December 2014, for $1,056.89 you would have bought 17 shares at $62.17 per share. In December 2024, after 10 years you would have received $229.13 in dividends. The stock would be worth $3,215.89. Your total return would have been $3,445.02. This would be a total return of 13.06% per year with 11.77% from capital gain and 1.29% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$62.17 $1,056.89 17 10 $229.13 $3,215.89 $3,445.02

The current dividend yield is low with dividend growth moderate. The current dividend is low (below 2%) at 1.01%. The 5, 10 and historical median dividend yields are also low at 1.46%, 1.51% and 1.46%. The dividends growth is moderate (8% to 14% range per year) at 9.9% per year over the past 5 years. The last dividend increase was in 2025 and it was for 10%.

The dividends are low, so if you buy this stock what sort of dividends would you get in the future. This chart is an attempt to show this. If dividends continue to increase by 9.87% as they have in the past 5 years, what you would get in dividends in 5, 10 and 15 years is shown in the Dividends Paid (Div Pd) column. The next column shows what your yield on the current stock price of $223.68 would be. The last column shows the percentage of your stock’s price would be covered by dividends in 5, 10 and 15 years.

Div Pd Div Yield Years At IRR Div Cov
$3.61 1.62% 5 9.87% 6.14%
$5.78 2.59% 10 9.87% 14.37%
$9.26 4.14% 15 9.87% 27.53%

The Dividend Payout Ratios (DPR) are good. The DPR for 2024 for Earnings per Share (EPS) is good at 28% with 5 year coverage at 31%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is good at 23% with 5 year coverage at 25%. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 9% with 5 year coverage at 9%. The DPR for 2024 for Free Cash Flow (FCF) is good at 18% with 5 year coverage at 17%.

Item Cur 5 Years
EPS 28.40% 30.59%
AEPS 23.22% 24.91%
CFPS 8.58% 8.54%
FCF 17.59% 17.38%

Some Debt Ratios are fine, but the company has too much debt. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.13 and currently at 0.12. The Liquidity Ratio for 2024 is low at 1.24 and 1.34 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.68 and currently at 1.75. The Debt Ratio for 2024 is low at 1.38 and 1.38 currently. The Leverage and Debt/Equity Ratios for 2024 are too high at 3.63 and 2.63 and currently at 3.61 and 2.61. It is best if the Leverage and D/E Ratios are below 3.00 and 2.00.

Type Year End Ratio Curr
Lg Term R 0.13 0.12
Intang/GW 0.17 0.14
Liquidity 1.24 1.34
Liq. + CF 1.68 1.75
Debt Ratio 1.38 1.38
Leverage 3.63 3.61
D/E Ratio 2.63 2.61

The Total Return per year is shown below for years of 5 to 36 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 9.87% 24.65% 23.07% 1.57%
2014 10 7.37% 13.06% 11.77% 1.29%
2009 15 5.90% 13.75% 12.15% 1.60%
2004 20 4.92% 5.89% 4.95% 0.94%
1999 25 8.82% 8.15% 6.95% 1.19%
1994 30 10.86% 13.22% 11.14% 2.08%
1989 35 10.18% 13.92% 11.75% 2.18%
1988 36 9.89% 14.87% 12.40% 2.47%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 16.96, 18.96 and 21.83. The corresponding 10 year ratios are 18.77, 22.52 and 25.39. The corresponding historical ratios are 17.03, 19.41 and 21.83. The current P/E Ratio is 30.81 based on a stock price of $223.68 and EPS estimate for 2025 of $7.26. This ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I also have Adjusted Earnings per Share (AEPS) Data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 14.23, 15.98 and 18.41. The corresponding 10 year ratios are 14.51, 16.10 and 18.36. The corresponding historical ratios are 13.71, 15.99 and 18.33. The current P/E Ratio is 23.52 based on a stock price of $223.68 and AEPS estimate for 2025 of $9.51. This ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a Graham Price of $89.03. The 10-year low, median, and high median Price/Graham Price Ratios are 1.16, 1.27 and 1.44. The current P/GP Ratio is 2.51 based on a stock price of $223.68. This ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 2.21. The current ratio is 6.04 based on a stock price of $223.68, Book Value of $11,0.31 and Book Value per Share of $37.04. The current ratio is 173% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have a Book Value per Share estimate for 2025 of $38.18. This implies a ratio of 5.86 based on a stock price of $223.68 and Book Value of $11,370M. This ratio is 165% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 7.84. The current P/CF Ratio is 13.08 based on Cash Flow per Share estimate for 2025 of $17.10, Cash Flow of $5,092M and a stock price of $223.68. The current ratio is 67% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 1.46%. The current dividend yield is 1.01% based on a stock price of $223.68 and dividends of $2.572. The current yield is 31% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 1.51%. The current dividend yield is 1.01% based on a stock price of $223.68 and dividends of $2.572. The current yield is 34% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

The 10-year median Price/Sales (Revenue) Ratio is 0.59. The current P/S Ratio is 1.03 based on Revenue estimate for 2025 of $64,777M, Revenue per Share of $217.52 and a stock price of $223.68. The current ratio is 74% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

Results of stock price testing is that the stock price is probably relatively expensive. The 10 year dividend yield test says this. It is confirmed by the P/S Ratio test. All the testing I have done is showing the stock price as relatively high. It is also very near it recent high.

When I look at analysts’ recommendations, I find Strong Buy (5), Buy (3), Hold (2), and Sell (1). The consensus would be a Buy. The 12 month stock price consensus is $235.09 with a high of $267.00 and low of $148.00. The consensus stock price of $235.09 implies a total return of 6.11% with 5.10% from capital gains and 1.01% from dividends based on a current stock price of $223.68.

Analysts on Stock Chase sees this company as a weak buy or a hold. They are mainly worried about tariffs affecting this company. That said, they seem to like this company. Jitendra Parashar on Motley Fool thinks this is a great stock to hold for decades. He does a great review of this stock. Sneha Nahata on Motley Fool thinks this is a solid stocks to buy and hold forever. The company put out a Press Release about their fourth quarter of 2024. The company put out a Press Release about their first quarter of 2025.

Simply Wall Street via Yahoo Finance reviews this stock. They have one warning of has a high level of debt.

Loblaw is Canada's largest retailer, operating approximately 2,500 food retail and pharmacy stores across the country. Beyond retail, Loblaw runs the PC Optimum loyalty program and also offers credit cards and insurance brokerage, which are collectively referred to as financial services. George Weston is Loblaw's controlling shareholder with a 53% stake. Its web site is here Loblaw Companies Ltd.

The last stock I wrote about was about was Ballard Power Systems Inc (TSX-BLDP, NASDAQ-BLDP) ... learn more. The next stock I will write about will be Stingray Digital Group Inc (TSX-RAY.A, OTC-STGYF) ... learn more on Monday, August 4, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, July 30, 2025

Ballard Power Systems Inc

Sound bite for Twitter is: Industrial Sector Stock. Results of stock price testing is that the stock price is probably relatively cheap. There are no dividends on this stock, so no dividend yield and no Dividend Payout Ratios (DPR). See my spreadsheet on Ballard Power Systems Inc.

Is it a good company at a reasonable price? This company has money from selling shares. It does have revenue but it has not earned any profit. It is testing as cheap, but cheap does not make it a good deal. Analysts give every recommendation, so there is a wide range of opinion on this stock.

I do not own this stock of Ballard Power Systems Inc (TSX-BLDP, NASDAQ-BLDP), but I used to. Back in 1997, I read about Ballard and fell in love with the idea of cars running with fuel cells. I could help save the environment and also make some money. It was very attractive. I sold this stock in 2006 because it had lost its attraction. It did not seem that Ballard fuel cells would be in any car anytime soon. I was ahead in 2000, but the stock started to fall in October 2000 and never recovered. In the end, I lost money on the stock after having it for over 8 years. My loss was 5.32% per year.

When I was updating my spreadsheet, I noticed that this stock had been recovering for a while and it reached a peak ($52.23) in 2021, but the company has been declining ever since. By December 2024 it was just $2.39. The stock price was down by 51% in 2024 and it is easy to see why. Revenue is down. Earnings losses are high. Operations Cash Flow is a higher negative.

If you had invested in this company in December 2014, for $1,000.14 you would have bought 422 shares at $2.37 per share. In December 2024, after 10 years you would have received $0.00 in dividends. The stock would be worth $1,008.58. Your total return would have been $1,008.58. This would be a total return of 0.08% per year with 0.08% from capital gain and 0.00% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$2.37 $1,000.14 422 10 $0.00 $1,008.58 $1,008.58

There are no dividends on this stock, so there is no dividend yield and no Dividend Payout Ratios (DPR).

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.04 and currently at 0.04. The Liquidity Ratio for 2024 is good at 9.28 and 9.00 currently. If you added in Cash Flow after dividends, the ratios go down to 7.82 and currently to 8.02. The Debt Ratio for 2024 is good at 7.45 and 7.36currently. The Leverage and Debt/Equity Ratios for 2024 are good at 1.16 and 0.16 and currently at 1.16 and 0.16.

Type Year End Ratio Curr
Lg Term R 0.04 0.04
Intang/GW 0.00 0.00
Liquidity 9.25 9.00
Liq. + CF 7.82 8.02
Debt Ratio 7.45 7.36
Leverage 1.16 1.16
D/E Ratio 0.16 0.16

The Total Return per year is shown below for years of 5 to 29 to the end of 2024 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 0.00% -23.76% -23.76% 0.00%
2014 10 0.00% 0.08% 0.08% 0.00%
2009 15 0.00% 1.23% 1.23% 0.00%
2004 20 0.00% -5.89% -5.89% 0.00%
1999 25 0.00% -10.72% -10.72% 0.00%
1995 29 0.00% -2.51% -2.51% 0.00%

The Total Return per year is shown below for years of 5 to 29 to the end of 2024 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 0.00% -25.39% -25.39% 0.00%
2014 10 0.00% -1.75% -1.75% 0.00%
2009 15 0.00% -0.86% -0.86% 0.00%
2004 20 0.00% -6.79% -6.79% 0.00%
1999 25 0.00% -10.64% -10.64% 0.00%
1995 29 0.00% -2.68% -2.68% 0.00%

The 5-year low, median, and high median Price/Earnings per Share Ratios are all negative so useless. The same is true about the 10 year and historical median P/E Ratios. I cannot do any P/E Ratio testing.

I cannot calculate a Graham Price because of the years negative earnings under this stock. In the past 30 years that I have information on this stock; it is only in 1998 that they had any earnings and it was $0.01. No one seems to expect anything else but earnings losses in the near future.

I get a 10-year median Price/Book Value per Share Ratio of 2.78. The current P/B Ratio is 0.87 based on a Book Value of $654M, Book Value per Share of 2.18 and a stock price of $1.89. The current ratio is 76% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap. This testing is in US$, but you will get a similar result in CDN$.

I cannot do any Price/Cash Flow per Share Ratio testing because the company has a negative Cash Flow.

I cannot do any dividend yield testing because this stock pays no dividend.

The 10-year median Price/Sales (Revenue) Ratio is 8.97. The current P/S Ratio is 6.09 based on Revenue estimate for 2025 of $93M, Revenue per Share of $0.31 and a stock price of $1.89. The current ratio is 32% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap

Results of stock price testing is that the stock price is probably relatively cheap. This is shown by the P/S Ratio test. The only other test I could do was the P/B Ratio test and that also said that the stock was cheap.

When I look at analysts’ recommendations, I find Strong Buy (3), Buy (2), Hold (17), Underperform (1), and Sell (1). The consensus would be a Hold. The 12 month stock price consensus is $1.449 ($1.056 US$) with a high price of $2.047 ($1.492 US$) and low of $0.984 ($.717 US$). The implies a total loss of 43.84%, all from a capital loss based on a current stock price of $2.58.

Analyst on Stock Chase are not sure that hydrogen is the way to go and are not sure that investing in this very small company is any good. Amy Legate-Wolfe on Motley Fool thinks now is the time to buy as the stock has been hammered. Adam Othman on Motley Fool says to buy this stock to build generation-spanning wealth while this stock has been beaten down so badly. The company put out a Press Release about their fourth quarter results for 2024. The company put out a Press Release about its first quarter of 2025 results.

Simply Wall Street via Yahoo Finance looks at who owns shares in this company and it is mostly the general public. Simply Wall Street has one warning out on this company of currently unprofitable and not forecast to become profitable over the next 3 years. Insider Monkey via Yahoo Finance says Ballard is among the 13 best Hydrogen and Fuel Cell Stocks to buy.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale, and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries. Its web site is here Ballard Power Systems Inc.

The last stock I wrote about was about was Savaria Corporation (TSX-SIS, OTC-SISXF) ... learn more. The next stock I will write about will be Loblaw Companies Ltd (TSX-L, OTC-LBLCF) ... learn more on Friday, August 1, 2025 around 5 pm. Tomorrow on my other blog I will write about Travel Insurance.... learn more on Thursday, July 31, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, July 28, 2025

Savaria Corporation

Sound bite for Twitter is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably still reasonable. Debt Ratios are good. The Dividend Payout Ratios (DPR) could still improve. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Savaria Corporation.

Is it a good company at a reasonable price? This has been a good stock for its shareholder so far. It has a niche market and this is generally good. It is always best to buy a stock you want to buy and hold over several years. It is testing as reasonable, but I would use caution as the stock is just off its latest high.

I do not own this stock of Savaria Corporation (TSX-SIS, OTC-SISXF). I got this stock off the Dividend Blogger site that no longer exists. I am always interested in dividend growth small cap stock. The first few years of accounting were rather confusing, but I think I figured them out in the end.

When I was updating my spreadsheet, I noticed that this company has been doing well for its shareholder. See the 10 year results below and results for years 5 to 23 further down in this blog entry. As far as insider selling and buy is concerned, for the people I am following, the Chairman and a Director was selling, but the CEO and one officer was buying. Most of the people I am following had no change.

If you had invested in this company in December 2014, for $1,000.50 you would have bought 230 shares at $4.35 per share. In December 2024, after 10 years you would have received $914.07 in dividends. The stock would be worth $4,574.70. Your total return would have been $5,488.77. This would be a total return of 20.84% per year with 16.42% from capital gain and 4.43% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$4.35 $1,000.50 230 10 $914.07 $4,574.70 $5,488.77

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 2.69%. The 5, 10 and historical median dividend yield is also moderate at 3.23%, 2.98% and 3.41%. The dividend growth is low (below 8% per year) at 4.1% per year over the past 5 years. The last dividend increase was in 2025 and it was for 3.9%.

The Dividend Payout Ratios (DPR) could still improve. The DPR for 2024 for Earnings per Share (EPS) is too high at 77% with 5 year coverage at 100%. The DPR for 2024 for Adjusted Earnings per Share (AEPS) is too high at 52% with 5 year coverage at 87%. This is a better ratio for DPR, but it would be best if these ratios were in the 40% range or lower. Analysts expect this to happen next year. The DPR for 2024 for Cash Flow per Share (CFPS) is good at 27% with 5 year coverage at 32%. The DPR for 2024 for Free Cash Flow (FCF) is good at 43% with 5 year coverage at 50%. There is no agreement on what the FCF is.

Item Cur 5 Years
EPS 77.16% 99.57%
AEPS 58.30% 87.03%
CFPS 27.26% 31.66%
FCF 43.82% 50.21%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.16 and currently at 0.08. The Liquidity Ratio for 2024 is good at 1.81 and 1.80 currently. The Debt Ratio for 2024 is good at 2.07 and 2.11 currently. The Leverage and Debt/Equity Ratios for 2024 are good at 1.94 and 0.94 and currently at 1.90 and 0.90.

Type Year End Ratio Curr
Lg Term R 0.16 0.16
Intang/GW 0.43 0.43
Liquidity 1.81 1.80
Liq. + CF 2.26 2.31
Debt Ratio 2.07 2.11
Leverage 1.94 1.90
D/E Ratio 0.94 0.90

The Total Return per year is shown below for years of 5 to 23 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 4.07% 10.47% 7.35% 3.12%
2014 10 14.97% 20.84% 16.42% 4.43%
2009 15 21.02% 31.35% 23.39% 7.96%
2004 20 13.73% 16.20% 13.12% 3.08%
2001 23 10.76% 17.30% 14.41% 2.89%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 21.69, 28.29 and 34.60. The corresponding 10 year ratios are 21.59, 27.18 and 34.74. The corresponding historical ratios are 14.54, 19.67 and 26.14. The current P/E Ratio is 21.43 based on a stock price of $20.04 and EPS estimate for 2025 of $0.94. The current ratio is below the low ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 18.85, 22.87 and 28.82. The corresponding 10 year ratios are 19.15, 24.48 and 30.01. The corresponding historical ratios are 14.64, 21.05 and 26.36. The current P/E Ratio is 18.91 based on a stock price of $20.04 and AEPS estimate for 2025 of $1.06. The current ratio is below the low ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a Graham Price of $13.78. The 10-year low, median, and high median Price/Graham Price Ratios are 1.28, 1.63 and 1.98. The current P/GP Ratio is 1.45 based on a stock price of $20.04. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. The high ratios on the Graham Price is saying that the stock is being priced as a growth stock.

I get a 10-year median Price/Book Value per Share Ratio of 2.61. The current ratio is 2.52 based on a Book Value of $592M, Book Value per Share of $7.96 and a stock price of $20.04. The current ratio is 3.5% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 15.36. The current ratio is 11.39 based on Cash Flow per Share estimate for 2025 of $1.76, Cash Flow of $130.9M and a stock price of $20.04. The current ratio is 26% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 3.41%. The current dividend yield is 2.69% based on a stock price of $20.04 and dividends of $0.54. The current ratio is 20.9% below the historical dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 2.98%. The current dividend yield is 2.69% based on a stock price of $20.04 and dividends of $0.54. The current ratio is 9.5% below the historical dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median.

The 10-year median Price/Sales (Revenue) Ratio is 1.76. The current P/S Ratio is 1.62 based on Revenue estimate for 2025 of $919M, Revenue per Share of $12.35 and a stock price of $20.04. The current ratio is 7.7% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably still reasonable. Most of the testing is saying that the stock price is relatively cheap to reasonable except for the dividend yield tests. The historical test says it is expensive and the 10 year median test says that it is reasonable but above the median. If you look at the chart, the stock price is off the recent high.

When I look at analysts’ recommendations, I find Strong Buy (1), and Buy (6). The consensus would be a Buy. The 12 month stock price is $24.29 with a high of $25.00 and low of $23.00. The consensus stock price of $24.29 implies a total return of 23.90% with 21.21% from capital gains and 2.69% from dividends based on a currently price of $20.04. Note that the stock price has hit highs of $20.61 in 2018, $22.42 in 2021 and recently $23.72 in 2024 before falling back again.

On Stock Chase some analysts like this company and some do not. They say it is ok, but not outstanding and that an investor should be careful. A worry is that they will be hit by Trump’s tariffs. Others think it is a good buy. Christopher Liew on Motley Fool thinks this stock is undervalued in its niche market. Rajiv Nanjapla on Motley Fool says he is bullish on due to its solid financials, growing addressable market, and growth initiatives. The company put out a Press Release about their fourth quarter of 2024. The company put out a Press Release about their first quarter of 2025.

Simply Wall Street via Yahoo Finance reviews this stock. They have 2 warnings out on this stock of large one-off items impacting financial results; and significant insider selling over the past 3 months.

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. Its web site is here Savaria Corporation.

The last stock I wrote about was about was TECSYS Inc (TSX-TCS, OTC-TCYSF) ... learn more. The next stock I will write about will be Ballard Power Systems Inc (TSX-BLDP, NASDAQ-BLDP) ... learn more on Wednesday, July 30, 2025 around 5 pm. Tomorrow on my other blog I will write about Social Media Scams.... learn more on Tuesday, July 28, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, July 25, 2025

TECSYS Inc

I have been looking at Well Health Technologies Corp (TSX-WELL, OTCQX-WHTCF). I noticed this stock when it was said it was about to acquire MyHealth Centres in Toronto. Today I bought 300 shares with my fooling around money. I investigated it and will produce a report on or around August 6. In the mean time here are two articles. An article dated October 17, 2024 talks about Hong Kong Billionaire Solian Chau buying a 14% stake in this company. There is an article on CANTECH about Stifel analyst Justin Keywood recommending this stock in June 2025.

Sound bite for Twitter is: Dividend Growth Tech. Results of stock price testing is that the stock price could still be reasonable, but be cautious. Debt Ratios are mostly fine. The Dividend Payout Ratios (DPR) are too high. The current dividend yield is low with dividend growth low. See my spreadsheet on TECSYS Inc.

Is it a good company at a reasonable price? I have done well on this stock, but I bought it with fooling around money because it is a small Tech stock. I do not believe in Tech stocks for the long term. I would be cautious with this stock, but it is off its recent high. It is testing as reasonable, but above the median.

I own this stock of TECSYS Inc (TSX-TCS, OTC-TCYSF). I came across this stock when I was looking for a dividend paying small cap stock as a filler stock. This is a small cap dividend paying stock that I like.

When I was updating my spreadsheet, I noticed I have done very well on this stock. I have had it since February 11, 2023 and bought more in January 2024. My total return is 25.42% with 22.98% from capital gains and 2.44% from dividends. I noticed that the Chairman, David Brereton has been selling some shares every year. Note that the financial year for this stock ends April 30 each year, so I am reviewing the fourth quarter for April 30, 2025.

If you had invested in this company in December 2014, for $1,000.00 you would have bought 125 shares at $8.00 per share. In December 2024, after 10 years you would have received $285.63 in dividends. The stock would be worth $5,731.25. Your total return would have been $6,016.88. This would be a total return of 20.33% per year with 19.08% from capital gain and 1.26% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$8.00 $1,000.00 125 10 $285.63 $5,731.25 $6,016.88

The current dividend yield is low with dividend growth low. The current dividend yield is low (below 1%) at just 0.92%. The 5, 10 and historical median dividend yields are also low at 0.85%, 1.11% and 1.28%. The current dividend growth is low (below 8% per year) at 7.5% per year over the past 5 years. The last dividend increase was in 2025 and it was for 6.3%.

The Dividend Payout Ratios (DPR) are too high. The DPR for 2024 for Earnings per Share (EPS) is far too high at 110% with 5 year coverage at 105%. The DPR for 2024 for Cash Flow per Share (CFPS) is too high at 57% with 5 year coverage at 57%. The DPR for 2024 for Free Cash Flow (FCF) is too high at 55% with 5 year coverage at 57%. There is no agreement on what the FCF is.

Item Cur 5 Years
EPS 110.00% 105.15%
CFPS 57.39% 57.39%
FCF 55.49% 57.27%

Debt Ratios are mostly fine. The Long Term Debt/Market Cap Ratio for 2024 is good at 0.00 and currently at 0.00. The Liquidity Ratio for 2024 is low at 1.32 and 1.32 currently. If you added in Cash Flow after dividends, the ratios are low at 1.32 and currently at 1.32. I prefer the Liquidity Ratios to be at 1.50 or higher. The Debt Ratio for 2024 is good at 2.03 and 2.03 currently. The Leverage and Debt/Equity Ratios for 2024 are good at 1.97 and 0.97 and currently at 1.97 and 0.97.

Type Year End Ratio Curr
Lg Term R 0.00 0.00
Intang/GW 0.04 0.04
Liquidity 1.32 1.32
Liq. + CF 1.32 1.32
Debt Ratio 2.03 2.03
Leverage 1.97 1.97
D/E Ratio 0.97 0.97

The Total Return per year is shown below for years of 5 to 26 to the end of 2024. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2019 5 7.49% 17.48% 16.49% 0.99%
2014 10 13.87% 20.33% 19.08% 1.26%
2009 15 13.41% 24.81% 23.02% 1.79%
2004 20 13.22% 19.87% 18.65% 1.22%
1999 25 7.82% 7.43% 0.39%
1998 26 11.26% 10.78% 0.48%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 108.63, 133.17 and 157.70. The corresponding 10 year ratios are 57.97, 90.92 and 107.52. The corresponding historical ratios are 15.31, 19.63 and 23.96. The current ratio is 79.94 based on a stock price of $37.08 and EPS estimate for 2026 of $0.47. The current ratio is between the low and median ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. The ratios are very high because of low EPS compared to the stock price.

I get a Graham Price of $7.09. The 10-year low, median, and high median Price/Graham Price Ratios are 3.10, 4.61 and 5.31. The current P/GP Ratio is 5.23 based on a stock price of $37.08. The current ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 5.25. The current P/B Ratio is 7.72 based on a stock price of $37.08, Book Value of $71.26M and Book Value per Share of $4.80. The current ratio is 47% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive

I get a 10-year median Price/Cash Flow per Share Ratio of 48.84. The current ratio is 113.31 based on Cash Flow for the last 12 months of $4.386M, Cash Flow per Share of $0.33 and a stock price of $37.08. The current ratio is 132% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 1.28%. The current dividend yield is 0.92% based on dividends of $0.34 and a stock price of $37.08. The current dividend yield is 28% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive.

I get a 10 year median dividend yield of 1.11%. The current dividend yield is 0.92% based on dividends of $0.34 and a stock price of $37.08. The current dividend yield is 17% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median.

The 10-year median Price/Sales (Revenue) Ratio is 2.78. The current P/S Ratio is 2.85 based on Revenue estimate for 2026 of $193M, Revenue per Share of $13.03 and a stock price of $37.08. The current ratio is 2% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

Results of stock price testing is that the stock price could still be reasonable, but be cautious. The 10 year dividend yield test says that the stock price is reasonable but above the median. This is confirmed by the P/S Ratio test. Other tests are either showing the same thing or that the stock price is expensive.

When I look at analysts’ recommendations, I find Strong Buy (1) and Buy (4). The consensus would be a Strong Buy. The 12 month stock price consensus is $48.20 with a high of $50.00 and low of $46.00. The consensus stock price of $48.20 implies a total return of 30.91% with 29.99% from capital gains and 0.92% from dividends based on a current price of $37.08.

There are two entries on Stock Chase for this stock for 2025. The last one lists this stock as a buy, the earlier one says Do Not Buy as this analyst does not like that the company has little in recurring revenue. Amy Legate-Wolfe on Motley Fool says invest in companies that use AI and this is one she likes. Christopher Liew on Motley Fool thinks this is Canadian Tech stock worth investing in. The company put out a Press Release on their fourth quarter ending in March 2025.

Simply Wall Street via Yahoo Finance reviews this stock and its dividends. I agree that it is currently paying out too much. Simply Wall Street has two warnings out on this stock of earnings have declined by 14% per year over past 5 years and significant insider selling over the past 3 months. Earnings are volatile. For insider selling over the past years, the CEO and CFO and one director I follow bought shares in the last year. However, the Chairman, who when I first stated to follow this stock had 30% of the shares in 2005. Over the past 20 years he has been selling some each year and he now owns 6% of the shares of this company.

TECSYS Inc is engaged in the development and sale of enterprise supply chain management software for distribution, warehousing, transportation logistics, point-of-use, and order management. It also provides related consulting, education, and support services. The company serves healthcare systems, services parts, third-party logistics, retail, and general wholesale distribution industries. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Europe, and other regions. Its web site is here TECSYS Inc.

The last stock I wrote about was about was Pulse Seismic Inc (TSX-PSD, OTC-PLSDF) ... learn more. The next stock I will write about will be Savaria Corporation (TSX-SIS, OTC-SISXF) ... learn more on Monday, July 28, 2025 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.